Dexamethasone (PF) 0.1% Ophthalmic Solution

Dexamethasone (PF) sterile ophthalmic solution for topical ophthalmic use. A steroid solution for treating pain and inflammation after surgery.

• Volume: 15ml drops
• Concentration: 0.1%
• We exclusively compound sterile Dexamethasone (PF) for ophthalmic use only
• Compounded in a sterile compounding facility that is <795>, <797> and <800> chapter compliant

References:

1. Chung JH, Kang YG, Kim HJ. Effect of 0.1% dexamethasone on epithelial healing in experimental corneal alkali wounds: morphological changes during the repair process. Graefes Arch Clin Exp Ophthalmol. 1998;236(7):537–545. PMID: 9672801. https://pubmed.ncbi.nlm.nih.gov/9672801/
2. Lam DS, Fan DS, Ng JS, Yu CB, Wong CY, Cheung AY. Steroid response in children. Clin Exp Ophthalmol. 2005;33(3):252–258. PMID: 15932528. https://pubmed.ncbi.nlm.nih.gov/15932528/
3. Fierz FC, Locher S, Bachmann L, Baenninger PB, Bochmann F, Kaufmann C, Mitrovic I, Rossi M, Thiel MA, Howell JP. Multiple use of preservative-free single dose unit dexamethasone 0.1% eye drops is safe within 24 hours. PMCID: PMC11331357. PMID: 38830728. https://pmc.ncbi.nlm.nih.gov/articles/PMC11331357/
4. Zhang G, Liu S, Yang L, Li Y. The role of dexamethasone in clinical pharmaceutical treatment for patients with cataract surgery. PMCID: PMC5776560. PMID: 29434822. https://pmc.ncbi.nlm.nih.gov/articles/PMC5776560/
5. Steinkjer T, Chen X, Khan AZ, Magno MS, Hammer H, Fineide F, Utheim TP. The effects of topical preservative-free dexamethasone 0.1% and artificial tear drops on dry eye disease parameters. Invest Ophthalmol Vis Sci. 2023;64(8):3993. Presented at ARVO Annual Meeting, New Orleans, LA, April 23–27, 2023. https://iovs.arvojournals.org/article.aspx?articleid=2788063
6. Cagini C, Pellegrino A, Iannone A, Cerquaglia A, Modugno A, Fiore T, Messina M. Comparison of anti-inflammatory effects of eye drops formulations after uncomplicated cataract surgery. PMCID: PMC7509714. PMID: 33015542. https://pmc.ncbi.nlm.nih.gov/articles/PMC7509714/